Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | SHL:ASX since announced | Transaction value |
---|---|---|
Medical Laboratories Duesseldorf | -1.54% | 197.50m |
Diagnosticum - PartG der Fachaerzte fuer Labormedizin der Fachaerzte fuer Mikrobiologie der Fachaerzte fuer Pathologie der Fachaerzte fuer Humangenetik Dr Scholz und Partner | 2.78% | 205.94m |
Data delayed at least 20 minutes, as of Jun 02 2023 07:10 BST.
0.32%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Cullen Capital Management LLCas of 31 Mar 2023 | 1.46m | 0.31% |
Boston Common Asset Management LLCas of 31 Mar 2023 | 23.33k | 0.01% |
Envestnet Asset Management, Inc.as of 28 Feb 2023 | 5.33k | 0.00% |
Boston Partners Global Investors, Inc.as of 28 Feb 2023 | 3.35k | 0.00% |
PNC Investments LLCas of 31 Mar 2023 | 1.17k | 0.00% |
Front Row Advisors LLCas of 31 Mar 2023 | 484.00 | 0.00% |
Cornerstone Planning Group LLCas of 31 Dec 2022 | 214.00 | 0.00% |
Financial Gravity Asset Management, Inc.as of 31 Mar 2023 | 24.00 | 0.00% |
First Horizon Advisors, Inc.as of 31 Mar 2023 | 15.00 | 0.00% |
Ativo Capital Management LLCas of 31 Mar 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2022 - 31 Mar 2023Source: FactSet Research Systems Inc.